Bexson Biomedical


Bexson Biomedical is dedicated to evolving medicine and enhancing lives through precision dosing of small molecules by improving bioavailability and unlocking new routes of administration. The company values transparency, evidence-driven approaches, creativity, and a patient-centric mindset. They focus on platform technologies with multiple applications and aim to stay at the forefront of clinical delivery to make a positive societal impact.

Industries

Health Care
Software
SaaS
IT Infrastructure
Pharmaceutical
Pharmaceutical Manufacturing

Nr. of Employees

small (1-50)

Bexson Biomedical

Santa Barbara, California, United States


Patents

Compositions of complexing agents

US-12636265-B2

View Details

Complexing agent salt formulations of pharmaceutical compounds

US-12472201-B2

View Details

Complexing agent salt formulations of pharmaceutical compounds

US-11534454-B2

View Details

Ketamine formulation for subcutaneous injection

US-10973780-B2

View Details

Products

Multivalent salt-based delivery platform

A multivalent salt (multivalent counterion) formulation platform designed to potentiate subcutaneous delivery and improve the bioavailability of existing small-molecule drugs.


Services

Collaborative development of delivery formulations and precision dosing strategies for small-molecule therapeutics, with the goal of enabling alternative administration routes and improving bioavailability.

Expertise Areas

  • Drug delivery for small molecules
  • Formulation chemistry
  • Subcutaneous administration development
  • Precision dosing
  • Show More (2)

Key Technologies

  • Multivalent salt / counterion chemistry
  • Subcutaneous drug delivery
  • Small-molecule formulation
  • Precision dosing platforms
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.